Beatriz M, Ruth B, Ismael GM, Mario PP, et al. First Confirmed Case of Nonimmediate Hypersensitivity to Fremanezumab during Chronic Migraine Treatment. Contact Dermatitis 2021 Dec 6. doi: 10.1111/cod.14018.
PMID: 34870868